Xolremdi is part of the
CXCR4 Antagonists class and treats
WHIM syndrome. CXCR4
Antagonists are used to treat WHIM Syndrome, AIDS, certain inflammatory and infectious diseases, and some forms on cancer. They work by blocking CXCR4 receptors, which prevents excessive activation of immune cells, thereby reducing inflammation and tissue damage. Xolremdi is only available as a brand name drug.